In recent report, researchers present findings from a Phase I/II clinical trial (NCT04954469) involving 54 patients with either congenital or acquired B-cell deficiency. These patients were administered a single subcutaneous dose of CoVac-1...
August 2023
Parkinson’s disease – new insights into immune cell landscape
In a recent study, researchers investigating Parkinson's disease, in a mouse model, revealed a significant shift in our understanding of neuroinflammatory mechanisms of the disease....
Using a virus to treat Pancreatic Cancer
In a recent paper, researchers described the development of a novel oncolytic virus (OV) called OV-mOX40L for the treatment of pancreatic cancer...
More robust immune systems in children from rural areas
In a recent paper, researchers have described the significant impact of early-life environment on children's immune system development...
Mapping macrophage diversity in liver diseases
In a recent review, researchers have described the hepatic immune landscape, focusing particularly on the dynamic nature of liver macrophages and their significance in various liver diseases...
T cells and type 1 diabetes prevention
In a recent paper, researchers have described a promising approach to identify individuals at risk of developing type 1 diabetes, a severe autoimmune disease, by analyzing T cells in the blood...
The potential of T cell activation markers for TB diagnostic development
In a recent paper, researchers tested the diagnostic capability of a simplified T cell activation markers (TAM)-based TB assay that takes real-time measurements from a millimetre of blood...